RUSNANO logo

RUSNANO

North America, California, United States, Menlo Park

Description

Rusnano is a joint-stock company aimed at commercializing developments in the nanotechnology industry.

Investor Profile

RUSNANO has made 87 investments, with 0 in the past 12 months and 51% as lead.

Stage Focus

  • Series Unknown (71%)
  • Series E (3%)
  • Series F (3%)
  • Series D (3%)
  • Private Equity (2%)
  • Series B (2%)
  • Series G (2%)
  • Series C (2%)
  • Series A (2%)
  • Post Ipo Equity (2%)

Country Focus

  • Russian Federation (61%)
  • United States (29%)
  • Germany (3%)
  • Finland (2%)
  • Luxembourg (1%)
  • Canada (1%)
  • Israel (1%)
  • The Netherlands (1%)

Industry Focus

  • Manufacturing
  • Semiconductor
  • Biotechnology
  • Electronics
  • Health Care
  • Biopharma
  • Industrial Manufacturing
  • Medical
  • Chemical
  • Chemical Engineering
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does RUSNANO frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 2
EV
Asia, Fujian, China, Taipei
Co-Investments: 2
I2BF Global Ventures
North America, New York, United States, New York
Co-Investments: 3
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
LI
North America, Massachusetts, United States, Chestnut Hill
Co-Investments: 2
Greylock
North America, California, United States, Menlo Park
Co-Investments: 3
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 2

Which angels does RUSNANO often collaborate with?

SH
North America, California, United States, Santa Monica
Shared Deals: 1

What are some of recent deals done by RUSNANO?

Panacela Labs

New York, New York, United States

Panacela Labs is a clinical-stage biotechnology company focusing on oncology and orphan drug development.

BiotechnologyHealth CareMedicalOncology
Series BDec 24, 2015
Amount Raised: $2,902,600
Selecta Biosciences

Watertown, Massachusetts, United States

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

BiopharmaBiotechnologyPharmaceutical
Series ESep 8, 2015
Amount Raised: $38,000,000
Motorica

Moscow, Moscow City, Russian Federation

Motorica focuses on research and development in modern technologies in medicine and robotics.

ManufacturingMedical DeviceRoboticsWearables
SeedSep 1, 2015
Amount Raised: $60,000
Crocus Technology

Santa Clara, California, United States

Crocus Technology provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries.

ElectronicsSemiconductorTelecommunications
Series EJun 16, 2015
Amount Raised: $21,000,000
KuibyshevAzot

Togliatti, Sakha, Russian Federation

KuibyshevAzot producer of caprolactam and polyamide-6 in the CIS and Eastern Europe.

Mineral
Series UnknownJan 19, 2015
Quantenna Communications

San Jose, California, United States

Quantenna specializes in providing Wi-Fi solutions.

SemiconductorSoftwareWireless
Series UnknownDec 17, 2014
Amount Raised: $22,000,000
Selecta Biosciences

Watertown, Massachusetts, United States

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

BiopharmaBiotechnologyPharmaceutical
Private EquityOct 15, 2014
Amount Raised: $20,000,000
SiTime

Sunnyvale, California, United States

SiTime Corporation is an analog semiconductor company offering MEMS-based silicon timing solutions.

ManufacturingSemiconductorSupply Chain Management
Series GSep 23, 2014
Amount Raised: $10,000,000
Aquantia

Milpitas, California, United States

Aquantia is a semiconductor company developing Ethernet connectivity solutions for cloud computing and next generation enterprise networks.

ElectronicsMobileSemiconductor
Series GMar 17, 2014
Amount Raised: $16,084,571
OCSiAl Group

Luxembourg, Luxembourg, Luxembourg

The only company to develop low-cost technology with unlimited scaling potential for the mass production of graphene nanotubes.

IndustrialManufacturingNanotechnology
UndisclosedJan 1, 2014
Amount Raised: $10,000,000